Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank G Schaap

Showing results (1-10 of 104) with videos related to

Pageof 11
Sort By:
Current Opinion in Clinical Nutrition and Metabolic Care|May 24, 2012
Role of fibroblast growth factor 19 in the control of glucose homeostasisFrank G Schaap
Journal of Hepatology|March 22, 2015
Intestinal failure to produce FGF19: A culprit in intestinal failure-associated liver disease?Karel J van Erpecum, Frank G Schaap
Hepatology (Baltimore, Md.)|October 15, 2013
How sweet it is to activate FXRPeter L M Jansen, Frank G Schaap
Hepatology (Baltimore, Md.)|November 25, 2015
Pandora's box opens for cholestatic liver diseasePeter L M Jansen, Frank G Schaap
Journal of Hepatology|February 14, 2015
Pituitary TSH controls bile salt synthesisPeter L M Jansen, Frank G Schaap
European Journal of Endocrinology|November 21, 2024
Advancing understanding of metabolic consequences of a cholecystectomy: Review reflectionStijn Bluiminck, Frank G Schaap, Philip R de Reuver
Nature Reviews. Gastroenterology & Hepatology|August 29, 2013
Bile acid receptors as targets for drug developmentFrank G Schaap, Michael Trauner, Peter L M Jansen
Hepatology (Baltimore, Md.)|July 11, 2020
Gut Microbes Take It to the Next Level? First Insights Into Farnesoid X Receptor Agonists of Microbial OriginMartin Lenicek, Steven W M Olde Damink, Frank G Schaap
Molecular Endocrinology (Baltimore, Md.)|July 30, 2005
Hepatocyte nuclear factor-4alpha regulates the human apolipoprotein AV gene: identification of a novel response element and involvement in the control by peroxisome proliferator-activated receptor-gamma coactivator-1alpha, AMP-activated protein kinase, and mitogen-activated protein kinase pathwayXavier Prieur, Frank G Schaap, Hervé Coste, et al.
Gastroenterology|January 28, 2012
Fibroblast growth factor 19, an anticholestatic drug produced by human liverPeter L M Jansen, Frank G Schaap, Ulrich H W Beuers
Pageof 11

Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Current Opinion in Clinical Nutrition and Metabolic Care|May 24, 2012
Role of fibroblast growth factor 19 in the control of glucose homeostasisFrank G Schaap
Journal of Hepatology|March 22, 2015
Intestinal failure to produce FGF19: A culprit in intestinal failure-associated liver disease?Karel J van Erpecum, Frank G Schaap
Hepatology (Baltimore, Md.)|October 15, 2013
How sweet it is to activate FXRPeter L M Jansen, Frank G Schaap
Hepatology (Baltimore, Md.)|November 25, 2015
Pandora's box opens for cholestatic liver diseasePeter L M Jansen, Frank G Schaap
Journal of Hepatology|February 14, 2015
Pituitary TSH controls bile salt synthesisPeter L M Jansen, Frank G Schaap
European Journal of Endocrinology|November 21, 2024
Advancing understanding of metabolic consequences of a cholecystectomy: Review reflectionStijn Bluiminck, Frank G Schaap, Philip R de Reuver
Nature Reviews. Gastroenterology & Hepatology|August 29, 2013
Bile acid receptors as targets for drug developmentFrank G Schaap, Michael Trauner, Peter L M Jansen
Hepatology (Baltimore, Md.)|July 11, 2020
Gut Microbes Take It to the Next Level? First Insights Into Farnesoid X Receptor Agonists of Microbial OriginMartin Lenicek, Steven W M Olde Damink, Frank G Schaap
Molecular Endocrinology (Baltimore, Md.)|July 30, 2005
Hepatocyte nuclear factor-4alpha regulates the human apolipoprotein AV gene: identification of a novel response element and involvement in the control by peroxisome proliferator-activated receptor-gamma coactivator-1alpha, AMP-activated protein kinase, and mitogen-activated protein kinase pathwayXavier Prieur, Frank G Schaap, Hervé Coste, et al.
Gastroenterology|January 28, 2012
Fibroblast growth factor 19, an anticholestatic drug produced by human liverPeter L M Jansen, Frank G Schaap, Ulrich H W Beuers
Pageof 11